DP2 receptor antagonists (Merck Serono)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDP2 receptor antagonists (Merck Serono)
Drug Alias NameCRTH2 receptor antagonist (Merck Serono)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonists
TargetsProstaglandin D2 receptor 2
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono Sa
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A